Literature DB >> 1780759

High-dose chemotherapy in adult acute lymphoblastic leukemia.

D Hoelzer1.   

Abstract

Entities:  

Mesh：

Year:  1991        PMID： 1780759

Source DB:  PubMed          Journal:  Semin Hematol        ISSN： 0037-1963            Impact factor:   3.851


× No keyword cloud information.
  5 in total

1.  High-dose Ara-C for remission induction and consolidation of previously untreated adults with ALL or lymphoblastic lymphoma.

Authors:  R Willemze; J M Zijlmans; G J den Ottolander; J C Kluin-Nelemans; J H Falkenburg; C W Starrenburg; J F van der Burgh; W E Fibbe
Journal:  Ann Hematol       Date:  1995-02       Impact factor: 3.673

2.  Southwest Oncology Group Study S0530: a phase 2 trial of clofarabine and cytarabine for relapsed or refractory acute lymphocytic leukaemia.

Authors:  Anjali S Advani; Holly M Gundacker; Olga Sala-Torra; Jerald P Radich; Raymond Lai; Marilyn L Slovak; Jeffrey E Lancet; Steve E Coutre; Robert K Stuart; Martha P Mims; Patrick J Stiff; Frederick R Appelbaum
Journal:  Br J Haematol       Date:  2010-12       Impact factor: 6.998

3.  Effects of vitamin D on the growth of normal and malignant B-cell progenitors.

Authors:  R Consolini; S Pala; A Legitimo; G Crimaldi; S Ferrari; S Ferrari
Journal:  Clin Exp Immunol       Date:  2001-11       Impact factor: 4.330

4.  SWOG S0910: a phase 2 trial of clofarabine/cytarabine/epratuzumab for relapsed/refractory acute lymphocytic leukaemia.

Authors:  Anjali S Advani; Shannon McDonough; Steven Coutre; Brent Wood; Jerald Radich; Martha Mims; Margaret O'Donnell; Stephanie Elkins; Michael Becker; Megan Othus; Frederick R Appelbaum
Journal:  Br J Haematol       Date:  2014-03-03       Impact factor: 6.998

5.  Prognostic significance of cell surface phenotype in acute lymphoblastic leukemia.

Authors:  Shiek Aejaz Aziz; Susheel Kumar Sharma; Iram Sabah; M Aleem Jan
Journal:  South Asian J Cancer       Date:  2015 Apr-Jun
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.